Allergic respiratory disease
MONDO:0000771A respiratory system disease with a basis in a pathological type I hypersensitivity reaction.
Also known as: allergic form of respiratory system disease, allergic respiratory system disease
206 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New allergy vaccine shows promise in early safety trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tests a new vaccine called PollenVax for people with moderate to severe mugwort pollen allergy. The main goal is to see if the vaccine is safe and tolerable in 30 adults aged 18 to 65. Participants receive four shots of either the vaccine or a placebo, and …
Phase: PHASE1 • Sponsor: Kazakh National Agrarian University • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 01, 2026 00:00 UTC
-
HPV vaccine shows promise for girls on Immune-Suppressing drugs
⭐️ VACCINE ⭐️ CompletedThis study looked at whether the HPV vaccine works in girls aged 9 to 17 who are taking medicines that weaken their immune system, such as after an organ transplant or for diseases like lupus. The goal was to see if their bodies produce enough antibodies to protect against HPV. T…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:36 UTC
-
Skin test may personalize asthma care for kids
Disease control CompletedThis study tests whether a skin test that measures histamine response can help doctors decide if adding an antihistamine (Levocetirizine) to standard asthma treatment improves control in children aged 6-17 with allergic asthma. About 300 African American/Black and Caucasian/White…
Phase: PHASE3 • Sponsor: Bridgette Jones • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New asthma drug JYB1904 shows promise in early trial
Disease control CompletedThis study tested a new drug, JYB1904, in 69 adults with allergic asthma. Participants received either JYB1904 every 8 weeks or the standard drug omalizumab every 2 to 4 weeks for 24 weeks. The goal was to see how the drug behaves in the body, how safe it is, and how well it cont…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a mask prevent breathing failure in obese ICU patients?
Disease control CompletedThis study looked at whether using a non-invasive ventilation (NIV) mask right after removing a breathing tube can prevent respiratory failure in obese intensive care patients. About 1000 obese adults were randomly assigned to receive either NIV or oxygen therapy. The goal was to…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New antibody drug shows promise for blocking asthma attacks
Disease control CompletedThis phase II trial tested a drug called huMAb OX40L in 29 adults with mild allergic asthma. The drug is an antibody designed to block a protein that triggers allergic reactions in the airways. Researchers measured whether it could prevent breathing problems caused by allergens, …
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New hope for allergy sufferers: three techniques battle stubborn symptoms
Disease control CompletedThis study looked at 84 people with severe allergic rhinitis (constant sneezing, runny nose, itching, stuffiness) that didn't improve with usual treatments. Researchers compared three procedures that target the nerve in the nose: surgical cutting, radiofrequency, and surface cobl…
Phase: NA • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New allergy shots show promise for dust mite sufferers
Disease control CompletedThis study tested a type of allergy immunotherapy (Clustoid® Max Forte) in 140 people aged 5 to 65 with dust mite allergies. The goal was to see if it reduces allergy and asthma symptoms and the need for medication over one year. Results were measured by symptom scores and medica…
Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Dietary supplement shows promise for controlling kids' asthma and allergy symptoms
Disease control CompletedThis study tested a dietary supplement containing immune-supporting nutrients and postbiotics in 40 children aged 5–12 with asthma and/or allergic rhinitis. The goal was to see if the supplement could improve symptom control over 6 months. Researchers also looked at changes in im…
Phase: NA • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Real-world study confirms mepolizumab cuts asthma attacks and steroid use
Disease control CompletedThis study followed 106 adults with severe eosinophilic asthma in Poland who received mepolizumab injections every 4 weeks for at least a year. Researchers tracked asthma attacks and the need for oral steroids before and during treatment. The goal was to see if the drug helps con…
Sponsor: Medical University of Lodz • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Radiation-Free lung MRI could change how we diagnose scarring lung disease
Diagnosis CompletedThis study tested whether a special lung MRI can replace CT scans for diagnosing idiopathic pulmonary fibrosis (IPF), a scarring lung disease. Researchers compared MRI to standard CT in 60 patients to see if MRI could spot the same key signs of IPF without using radiation. The go…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
MRI may offer Radiation-Free diagnosis for lung fungal allergy
Diagnosis CompletedThis study tested whether MRI can accurately detect lung abnormalities caused by allergic bronchopulmonary aspergillosis (ABPA), a fungal allergy. Researchers compared MRI results to standard CT scans in 25 adults with ABPA or severe asthma. If MRI works well, it could provide a …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Which lung biopsy is safest and most accurate? new study has answers
Diagnosis CompletedThis study looked at three ways to take a small sample of lung tissue (biopsy) in 60 adults with interstitial lung diseases. The goal was to find which method gives the most accurate diagnosis and causes the fewest side effects. The methods tested were forceps biopsy, cryobiopsy …
Phase: NA • Sponsor: Mansoura University • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Could a probiotic gummy help kids with allergies?
Symptom relief CompletedThis study tests whether a probiotic gummy containing Weizmannia coagulans BC99 can reduce symptoms of allergic rhinitis (hay fever) in children aged 4 to 14. Over 8 weeks, half the children receive the probiotic gummy and half receive a placebo. Researchers track changes in nasa…
Phase: NA • Sponsor: Wecare Probiotics Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Acupuncture threads offer new hope for allergy sufferers?
Symptom relief CompletedThis study tested whether adding thread embedding acupuncture (TEA) to standard steroid nasal spray helps people with allergic rhinitis. 64 adults took part. The goal was to see if the combination reduces symptoms like sneezing and stuffy nose better than the spray alone, and whe…
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Can a light device replace steroid sprays for hay fever?
Symptom relief CompletedThis study tested whether a home-use light device (rhinophototherapy) can reduce nasal inflammation and allergy symptoms as well as a standard steroid spray. Thirty-five adults with allergic rhinitis used either the light device for 4.5 minutes three times daily or a steroid spra…
Phase: NA • Sponsor: National University of Malaysia • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Quick-Relief nasal spray combo tested for kids with stubborn allergies
Symptom relief CompletedThis study tested whether adding a decongestant nasal spray for the first 5 days to standard steroid spray treatment helps children with persistent allergic rhinitis feel better faster. 76 children aged 4-18 were randomly assigned to receive either steroid spray alone for 4 weeks…
Phase: PHASE4 • Sponsor: Dr. Behcet Uz Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Can a probiotic tame hay fever? new study investigates
Symptom relief CompletedThis completed trial tested whether a probiotic called Bifidobacterium longum ES1, or its heat-treated version, could reduce symptoms of allergic rhinitis (hay fever) in 72 adults with moderate-to-severe dust mite allergies. Participants took daily capsules for several weeks and …
Phase: NA • Sponsor: Fundació Eurecat • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New grass allergy shot shows promise in reducing hay fever misery
Symptom relief CompletedThis study tested an investigational treatment called PQ Grass 27600 SU in 119 adults with seasonal grass pollen allergies (hay fever). The goal was to see if it could reduce allergy symptoms and the need for relief medications during peak grass pollen season. Participants receiv…
Phase: PHASE2, PHASE3 • Sponsor: Allergy Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New nasal spray shows promise for ragweed allergy sufferers
Symptom relief CompletedThis study tested an experimental nasal spray called INI-2004 in 78 adults with ragweed allergies. Participants received either the spray or a placebo once a week for four weeks, then spent time in a room filled with ragweed pollen to see if symptoms improved. The goal was to che…
Phase: PHASE2 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New combo therapy may offer lasting hay fever relief
Symptom relief CompletedThis study looked at whether taking a grass pollen tablet (SLIT) together with the drug dupilumab for 2 years can help adults with moderate to severe hay fever tolerate grass pollen better, even after stopping treatment. About 199 participants were involved. The main goal was to …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Ancient oil could be new hope for stuffy nose sufferers
Symptom relief CompletedThis study tested a nasal spray made from pistacia lentiscus oil (Bactorinol) in 120 adults with vasomotor rhinitis, a chronic condition causing nasal congestion and runny nose. Participants used the spray or a saline placebo for 20 days. The goal was to see if the oil spray impr…
Phase: NA • Sponsor: Liaquat University of Medical & Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New hope for teens with severe hay fever: xolair shows promise
Symptom relief CompletedThis study tested Xolair (omalizumab) in 50 teenagers aged 12 to 17 with severe seasonal allergic rhinitis (hay fever) that standard treatments couldn't control. Researchers tracked side effects and how much symptoms improved. The goal was to see if Xolair is safe and effective i…
Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can acupuncture beat nasal spray for stuffy noses?
Symptom relief CompletedThis small study tested whether acupuncture can relieve nasal congestion in people with allergic rhinitis. Eleven adults received either acupuncture or a standard nasal spray for 6 weeks. The goal was to see if acupuncture offers a safe, side-effect-free option for stuffy noses.
Phase: NA • Sponsor: Johanna Maria Vermeulen • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New supplement shows promise for hay fever relief
Symptom relief CompletedThis study tested whether a supplement called M-Gard can help relieve symptoms of seasonal grass pollen allergies (hay fever). Twenty healthy adults with a history of grass allergies took M-Gard or a placebo in a crossover design. Researchers measured symptom severity like nasal …
Phase: PHASE2 • Sponsor: RDC Clinical Pty Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could a tiny dose of muscle relaxant make lung scopes safer?
Symptom relief CompletedThis study looked at whether giving a low dose of a muscle relaxant (rocuronium) during bronchoscopy—a procedure where a tube is inserted into the lungs—could reduce complications like throat spasms and coughing. 153 adults having elective bronchoscopy were split into two groups:…
Phase: NA • Sponsor: Harbin Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New study checks allergy Pill's safety and symptom relief
Symptom relief CompletedThis study tested the safety and effectiveness of Allegra D (fexofenadine plus pseudoephedrine) in 203 people aged 12 and older with allergic rhinitis. Participants took the medication for up to 13 days, and researchers tracked side effects and symptom improvement using nasal and…
Phase: PHASE4 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New allergy pill shows promise in ragweed season trial
Symptom relief CompletedThis study tested a new drug called BLU-808 in 21 adults with ragweed allergies. The goal was to see if it is safe and helps reduce sneezing, runny nose, and itchy eyes caused by ragweed pollen. Participants were exposed to ragweed in a special chamber to measure the drug's effec…
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New allergy shot shows promise in early trial
Symptom relief CompletedThis Phase 2 trial tested an injection called TQC2938, a humanized monoclonal antibody, in 136 adults with seasonal allergic rhinitis. All participants also used a standard nasal spray. The study measured how well the injection reduced nasal symptoms like sneezing and congestion …
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Could an apple a day keep allergy symptoms away?
Symptom relief CompletedThis study tested whether apple fruit extract, which has antioxidant and anti-inflammatory properties, could improve symptoms of allergic rhinitis (hay fever). Forty adults with persistent allergies received either standard treatment plus apple extract or standard treatment alone…
Phase: NA • Sponsor: Universitas Sebelas Maret • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can ectoin sprays and drops soothe hay fever? new study investigates
Symptom relief CompletedThis study tested whether Ectoin allergy nasal spray and eye drops can relieve symptoms of hay fever (runny nose, sneezing, itchy eyes) better than a placebo. 46 adults with ragweed allergies were exposed to pollen in a special chamber. Researchers measured symptom scores and nas…
Phase: NA • Sponsor: Bitop AG • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Allergy sufferers: new nasal spray study offers hope for symptom relief
Symptom relief CompletedThis study tested whether an ectoine nasal spray works better than a cromoglycic acid spray for easing allergic rhinitis symptoms like a stuffy nose, runny nose, and sneezing. Fifty adults with proven allergies used one of the two sprays for 14 days. Doctors and patients rated ho…
Sponsor: Bitop AG • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New allergy drug shows promise in early trial
Symptom relief CompletedThis early-stage study tested a new drug called INI-2004 in 68 healthy people and those with ragweed allergies. The goal was to check safety and how well it reduces nasal symptoms like sneezing and congestion. Researchers gave single or multiple doses and monitored side effects a…
Phase: PHASE1 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New nasal spray for allergies passes first safety check
Symptom relief CompletedThis early-stage trial tested the safety and tolerability of a new corticosteroid nasal spray called PA9159 in 36 healthy Chinese adults. Participants received either a single dose or seven daily doses of the spray, or a placebo. The goal was to find the maximum safe dose and see…
Phase: PHASE1 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New hope for cedar fever sufferers: drug eases severe allergy symptoms
Symptom relief CompletedThis study tested a drug called omalizumab in 337 adults and teens with severe Japanese cedar pollen allergy (hay fever) that standard medicines couldn't control. Participants received either omalizumab or a placebo on top of their usual allergy treatments for 12 weeks. The goal …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can this antihistamine tablet ease Kids' constant stuffy noses?
Symptom relief CompletedThis study tested whether the drug TAU-284 (bepotastine besilate) can reduce sneezing, runny nose, and congestion in children aged 7 to 15 with perennial allergic rhinitis (year-round nasal allergies). In a double-blind, placebo-controlled design, 473 children took either the dru…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New allergy pill shows promise for kids with constant stuffy nose
Symptom relief CompletedThis study tested a medicine called TAU-284 in 490 children aged 7 to 15 who have year-round nasal allergies. The goal was to see if it reduces sneezing, runny nose, and congestion better than a placebo. The trial was completed and focused on symptom relief, not a cure.
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New allergy pill shows promise for kids in Long-Term trial
Symptom relief CompletedThis study tested the long-term safety and effectiveness of TAU-284 (bepotastine besilate) in 58 children aged 7 to 15 with perennial allergic rhinitis (year-round nasal allergies). Over 12 weeks, researchers tracked side effects and changes in sneezing, runny nose, and congestio…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New allergy shot shows promise for those failed by standard meds
Symptom relief CompletedThis study tested a new drug called LP-003 in 180 adults with moderate to severe seasonal allergic rhinitis (hay fever) that wasn't well controlled by usual treatments like antihistamines or nasal sprays. LP-003 is an antibody that blocks IgE, a key driver of allergic reactions, …
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New allergy drug shows promise in early trial
Symptom relief CompletedThis early-stage study tested a single dose of the investigational drug MT-2990 in 75 adults with seasonal allergic rhinitis triggered by Japanese cedar pollen. The main goals were to check the drug's safety, how the body processes it, and whether it can reduce allergy symptoms w…
Phase: PHASE1 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New birch allergy treatment shows promise for kids in major trial
Symptom relief CompletedThis study tested a medication called STALORAL Birch 300 IR in 553 children aged 5 to 17 with birch pollen allergies. The goal was to see if it safely reduces symptoms like sneezing, runny nose, and itchy eyes during pollen season. Participants received the treatment or a placebo…
Phase: PHASE3 • Sponsor: Stallergenes Greer • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can kids with allergies use nasal spray only when needed? new study investigates.
Symptom relief CompletedThis study looked at whether children with year-round allergic rhinitis can use a nasal steroid spray only when symptoms bother them, instead of every day. Sixty-eight children aged 6 to 18 were randomly assigned to either daily use or as-needed use of fluticasone furoate spray. …
Phase: PHASE3 • Sponsor: Mahidol University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can probiotic gummies soothe Kids' allergies?
Symptom relief CompletedThis completed study tested whether probiotic gummies can relieve allergic rhinitis symptoms in children aged 4 to 14. Over 56 days, 72 kids took either the probiotic or a placebo, and researchers tracked nasal symptoms, quality of life, and gut health. The goal was to see if pro…
Phase: NA • Sponsor: Wecare Probiotics Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can a tiny dose of IL-2 tame hay fever?
Symptom relief CompletedThis study tested whether a low dose of IL-2 (a protein that helps regulate the immune system) could reduce nasal symptoms in people with birch pollen allergy. Twenty-four adults with a history of seasonal allergies received either the drug or a placebo over several months. The g…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 26, 2026 18:23 UTC
-
New nasal spray aims to sneeze away dust mite allergies
Symptom relief CompletedThis study tested a nasal spray called AD17002 in 48 adults with house dust mite allergic rhinitis. The goal was to see if it is safe and can reduce symptoms like sneezing, runny nose, and congestion. Participants received either the spray or a placebo, and researchers monitored …
Phase: PHASE1, PHASE2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 17:38 UTC
-
Early allergy pill may stop sneezing before it starts
Symptom relief CompletedThis study tested whether taking the allergy drug fexofenadine for two days before ragweed season can reduce symptoms like sneezing and runny nose. 95 adults with ragweed allergies were randomly given either fexofenadine or a placebo. Researchers measured nasal symptoms over six …
Phase: PHASE3 • Sponsor: Opella Healthcare Group SAS, a Sanofi Company • Aim: Symptom relief
Last updated Jun 26, 2026 15:14 UTC
-
Mystery autumn allergies traced to birch rust?
Knowledge-focused CompletedThis study investigates whether spores from birch rust fungi trigger seasonal allergies in autumn. Researchers will compare 30 people with suspected birch rust allergy to 15 non-allergic controls, tracking symptoms and spore levels. The goal is to understand a possible cause of a…
Sponsor: University Hospital of North Norway • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Pigeon Lovers' lung disease: genes may hold the key
Knowledge-focused CompletedThis study looked at whether certain genes make people who are regularly around pigeons more likely to develop a type of lung disease called hypersensitivity pneumonitis. Researchers analyzed the DNA of 475 pigeon fanciers to find genetic markers linked to lung scarring. The goal…
Sponsor: University of Dundee • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
SNIFF TEST: nasal swab may reveal lung disease severity
Knowledge-focused CompletedThis completed study looked at whether substances in nasal fluid can help doctors objectively measure the severity of respiratory conditions like asthma, COPD, hayfever, and sinusitis. Researchers collected samples from 111 adults (including healthy volunteers) using a small nasa…
Sponsor: Diag-Nose Medical Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Scientists compare nose and lung cells to unlock allergy secrets
Knowledge-focused CompletedThis study looked at gene activity in cells from the nose and lungs of 44 healthy and allergic adults. The goal was to understand how allergies change these cells and why the nose and lungs react differently. Researchers hope this knowledge will lead to better treatments for alle…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Do parents know how air pollution affects their allergic kids? new study finds out.
Knowledge-focused CompletedThis study surveyed 500 parents of children with asthma or allergic rhinitis to see how much they know about air quality and pollution. The goal was to understand their awareness, knowledge, and protective behaviors. The results will help design better education and prevention pr…
Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Home visits may ease asthma and allergy symptoms in kids
Knowledge-focused CompletedThis study looked at whether a home visit by an environmental counselor can improve the quality of life for children with asthma or allergic rhinitis. Researchers checked the children's health at the start and again six months after the visit using standard questionnaires. The st…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Blood test may predict who benefits from dust mite allergy treatment
Knowledge-focused CompletedThis completed Phase 1 study tested whether two substances in the blood (sST2 and miR-223) can help predict how well patients with dust mite allergies respond to a six-month course of under-the-tongue immunotherapy (SLIT). Fifty-four patients with moderate-to-severe allergic rhin…
Phase: PHASE1 • Sponsor: Zagazig University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Asthma and obesity study probes Dupilumab's cellular effects
Knowledge-focused CompletedThis study looked at how the drug dupilumab changes gene and protein activity in airway cells from adults with asthma and obesity. Researchers compared allergic and non-allergic participants to understand different treatment responses. The goal was to gather knowledge, not to tes…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Scientists track how allergies fade away naturally
Knowledge-focused CompletedThis study looked at how the body naturally stops allergic inflammation after being exposed to grass pollen. Researchers measured specific molecules in the nose that help control and resolve the allergic response. Twenty adults with grass pollen allergies participated. The goal w…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Scientists gather clues on mysterious immune defects
Knowledge-focused CompletedThis study collected blood, saliva, stool, urine, and skin samples from 19 people with unknown or poorly understood immune system problems. The goal was to learn how different parts of the immune system work together. No treatments or drugs were tested. Participants were followed…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Study reveals Real-World allergy care for kids
Knowledge-focused CompletedThis study observed how private pediatricians in France manage allergic rhinitis (hay fever) in children under 18. Over 1,000 children participated, and researchers collected data on current treatment practices, including how many kids might be eligible for allergy immunotherapy.…
Sponsor: ALK-Abelló A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Grass allergy test study seeks better standardization
Knowledge-focused CompletedThis study aimed to find the right strength of two grass allergen extracts (timothy and orchard grass) to cause a skin reaction similar to histamine. Thirty-one adults with grass pollen allergies received skin prick tests with different concentrations. The goal was to improve all…
Phase: NA • Sponsor: Inmunotek S.L. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Scientists grow mini lung tissue from blood to study severe asthma
Knowledge-focused CompletedThis completed study took blood samples from 4 people with severe asthma or a related condition called ABPA. Researchers used the blood cells to create stem cells and then grew them into tiny models of bronchial tissue. The goal was to see if this lab-grown tissue could mimic rea…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Nose shape linked to allergies in kids?
Knowledge-focused CompletedThis study examined 69 children aged 6 to 14 to see if a deviated nasal septum (a crooked wall inside the nose) is linked to allergic rhinitis (hay fever). Researchers compared kids with and without the deviation using allergy tests, nasal samples, and quality-of-life questionnai…
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Could a dissolved allergy tablet replace the old nasal test for birch pollen?
Knowledge-focused CompletedThis completed study tested whether a dissolved allergy tablet (Itulazax) can be used as a nasal spray to diagnose birch pollen allergy. 89 participants received either the dissolved tablet or a saltwater spray, and their nasal symptoms and airflow were measured. The goal was to …
Phase: NA • Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:37 UTC
-
Doctors test which score best predicts lung disease survival
Knowledge-focused CompletedThis completed study looked at 143 people with two types of lung scarring diseases (IPF and hypersensitivity pneumonitis). Researchers compared three different scoring systems (GAP, ILD-GAP, and CPI) to see which one best predicts how long patients might live. The goal was to fin…
Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:07 UTC